Tubulis announced today that the first patient has been treated in its first Phase I/IIa trial (NAPISTAR 1-01, NCT06303505). The study is evaluating T ...

Pancreatic cancer (pancreatic ductal adenocarcinoma [PDAC]) is the fourth-leading cause of cancer death in the United States. The American Cancer Society 1 has estimated that 62,210 new cases of ...

Pancreatic ductal adenocarcinoma (PDAC) has a rising worldwide incidence and mortality rate, with some improvement in overall 5-year survival in recent decades. 1-3 Although there has been a modest ...